Markus Warmuth - CEO @ Monte Rosa Therapeutics

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

112,264

Primary Job Title CEO
Primary Organization
Monte Rosa Therapeutics

Location Boston, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn
X (Twitter) View on X

Markus Warmuth is based out of Boston, Massachusetts, and is the CEO of Monte Rosa Therapeutics. Markus previously worked at IMV as a Independent Board Member. Markus Warmuth attended Ludwig-Maximilians-Universität München.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Monte Rosa Therapeutics	Versant Ventures	—	Series C - Monte Rosa Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Monte Rosa Therapeutics	Versant Ventures	—	Series B - Monte Rosa Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Monte Rosa Therapeutics	Versant Ventures	—	Series A - Monte Rosa Therapeutics	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Markus Warmuth

is the

CEO

Monte Rosa Therapeutics

. Additionally,

Markus Warmuth

has had

past job as the

President and Chief Executive Officer

H3 Biomedicine

Monte Rosa Therapeutics CEOSep 2019

Organization Name	Title At Company	Start Date	End Date
H3 Biomedicine	President and Chief Executive Officer	Oct 2011	May 2018

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Markus Warmuth

is the

Member Board Of Directors

Ventus Therapeutics

Ventus Therapeutics Member Board Of DirectorsSep 2021

Organization Name	Title At Company	Start Date	End Date
IMV	Independent Board Member	Nov 2018	Oct 2023

Related Hubs

Hub Name	CB Rank (Hub)
Medical Public Companies With More Than 50 Employees	10,997
Medical Public Companies With Fewer Than 1000 Employees	20,245
Companies that Went Public in 2021	8,527
Google Ventures Portfolio Companies	30,023
Therapeutics Public Companies With Fewer Than 1000 Employees	15,367
Biotechnology Public Companies With More Than $1M in Revenue	7,232
Biotechnology Public Companies With Fewer Than 1000 Employees	7,610
HBM Healthcare Investments Portfolio Companies	34,450
Sixty Degree Capital Portfolio Companies	76,002
Medical Public Companies With More Than 100 Employees	11,506

Education

Markus Warmuth

studied at

Ludwig-Maximilians-Universität München

Ludwig-Maximilians-Universität München MDMedicine19911998